Bioequivalence

We count on the best professional staff and an extensive experience in the production of a large number of clinical studies to demonstrate bioequivalence of a drug product:
Feasibility Analysis: Of studies in or outside Chile.

Presentation of studies: Starting Protocols and Studies as such (results).

Studies: Under a strategic alliance between Austral Investments (Tecnilex) and CITCO Chile, the latter a company with extensive presence and experience in the Indian market and Chile, has been obtained the exclusive representation of AZIDUS Bioequivalence Center, recognized by ordinary office No. 1058 of May 24, 2011 issued by the Public Health Institute in favor of CITCO Chile.
Azidus has conducted and presented a large number of studies for major national laboratories.
AZIDUS has developed great experience, allowing the standardization of most of their processes, thereby resulting in accurate projection of time and costs, without contingencies or uncertainties.